表紙
市場調查報告書

呼吸道融合病毒(RSV)診斷藥的全球市場:2019年∼2023年

Global Respiratory Syncytial Virus (RSV) Diagnostics Market 2019-2023

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 773847
出版日期 內容資訊 英文 111 Pages
訂單完成後即時交付
價格
呼吸道融合病毒(RSV)診斷藥的全球市場:2019年∼2023年 Global Respiratory Syncytial Virus (RSV) Diagnostics Market 2019-2023
出版日期: 2018年12月27日內容資訊: 英文 111 Pages
簡介

供應商開發提高效率的新的RSV診斷產品。推出這些將有助於公司的收入,並推動市場。這些先進的產品發布將使最終用戶可以獲取產品,並將減少診斷所需的時間。Technavio的分析師預測,到2023年,呼吸道融合病毒(RSV)診斷市場的年複合成長率將超過9%。

本報告提供全球呼吸道融合病毒(RSV)診斷藥市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 報告的範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模(2018年)
  • 市場規模及預測(2018年∼2023年)

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各產品

  • 市場區隔:各產品
  • 各產品比較:市場規模及預測(2018年∼2023年)
  • 消耗品
  • 系統
  • 各產品

第7章 客戶形勢

第8章 地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2018年∼2023年)
  • 南北美洲
  • 歐洲、中東、非洲地區
  • 亞太地區
  • 主要國家
  • 市場機會

第9章 成長要素與課題

  • 市場成長要素
  • 市場課題

第10章 市場趨勢

  • 技術的進步

第11章 業者情勢

  • 概要
  • 創造性破壞狀況
  • 競爭模式

第12章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Abbott
  • BD
  • bioMerieux
  • F. Hoffmann-La Roche
  • Quidel

第13章 附錄

  • 調查方法
  • 簡稱的清單
目錄
Product Code: IRTNTR30578

About this market

Vendors are developing new RSV diagnostics products with increased efficiencies. These launches will contribute to the revenue of companies, which will drive the market. These advanced product launches will make products accessible for end- users and will decrease the time required for diagnostics. Technavio's analysts have predicted that the respiratory syncytial virus (RSV) diagnostics market will register a CAGR of over 9% by 2023.

Market Overview

Growing number of M&A

Core reference laboratories or large laboratories are focusing on increasing their presence in the global market through M&A. hence, large laboratories are acquiring small and medium- sized laboratories which conduct testing on infectious diseases.

Product recalls

Product recalls affect the sales and earnings of vendors for short periods and adversely impact their operations for extended periods. Therefore, the recalls of medical products or assays can limit the adoption of other systems and consumables developed by these companies.

For the detailed list of factors that will drive and challenge the growth of the respiratory syncytial virus (RSV) diagnostics market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Consumables - Market size and forecast 2018-2023
  • Systems - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 10: TRENDS

  • Technological advancements

PART 11: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 12: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • BD
  • bioMerieux
  • F. Hoffmann-La Roche
  • Quidel

PART 13: APPENDIX

  • Research methodology
  • List of abbreviations

List of Exhibits

  • Exhibit 01: Years in consideration
  • Exhibit 02: Global in-vitro diagnostics (IVD) market
  • Exhibit 03: Segments of global in-vitro diagnostics (IVD) market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market segments
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2018
  • Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 10: Five forces analysis 2018
  • Exhibit 11: Five forces analysis 2023
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2018
  • Exhibit 18: Product - Market share 2018-2023 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Consumables - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 21: Consumables - Year-over-year growth 2019-2023 (%)
  • Exhibit 22: Systems - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 23: Systems - Year-over-year growth 2019-2023 (%)
  • Exhibit 24: Market opportunity by product
  • Exhibit 25: Customer landscape
  • Exhibit 26: Market share by geography 2018-2023 (%)
  • Exhibit 27: Geographic comparison
  • Exhibit 28: Americas - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 29: EMEA - Year-over-year growth 2019-2023 (%)
  • Exhibit 30: Top 3 countries in EMEA
  • Exhibit 31: APAC - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 32: APAC - Year-over-year growth 2019-2023 (%)
  • Exhibit 33: Key leading countries
  • Exhibit 34: Market opportunity
  • Exhibit 35: Decision framework
  • Exhibit 36: Product launches by companies
  • Exhibit 37: Product recalls
  • Exhibit 38: Impact of drivers and challenges
  • Exhibit 39: Vendor landscape
  • Exhibit 40: Landscape disruption
  • Exhibit 41: Vendors covered
  • Exhibit 42: Vendor classification
  • Exhibit 43: Market positioning of vendors
  • Exhibit 44: Abbott - Vendor overview
  • Exhibit 45: Abbott - Business segments
  • Exhibit 46: Abbott - Organizational developments
  • Exhibit 47: Abbott - Geographic focus
  • Exhibit 48: Abbott - Segment focus
  • Exhibit 49: Abbott - Key offerings
  • Exhibit 50: Abbott - Key customers
  • Exhibit 51: BD - Vendor overview
  • Exhibit 52: BD - Business segments
  • Exhibit 53: BD - Organizational developments
  • Exhibit 54: BD - Geographic focus
  • Exhibit 55: BD - Segment focus
  • Exhibit 56: BD - Key offerings
  • Exhibit 57: BD - Key customers
  • Exhibit 58: bioMerieux - Vendor overview
  • Exhibit 59: bioMerieux - Business segments
  • Exhibit 60: bioMerieux - Organizational developments
  • Exhibit 61: bioMerieux - Geographic focus
  • Exhibit 62: bioMerieux - Segment focus
  • Exhibit 63: bioMerieux - Key offerings
  • Exhibit 64: bioMerieux - Key customers
  • Exhibit 65: F. Hoffmann-La Roche - Vendor overview
  • Exhibit 66: F. Hoffmann-La Roche - Business segments
  • Exhibit 67: F. Hoffmann-La Roche - Organizational developments
  • Exhibit 68: F. Hoffmann-La Roche - Geographic focus
  • Exhibit 69: F. Hoffmann-La Roche - Segment focus
  • Exhibit 70: F. Hoffmann-La Roche - Key offerings
  • Exhibit 71: F. Hoffmann-La Roche - Key customers
  • Exhibit 72: Quidel - Vendor overview
  • Exhibit 73: Quidel - Product segments
  • Exhibit 74: Quidel - Organizational developments
  • Exhibit 75: Quidel - Geographic focus
  • Exhibit 76: Quidel - Segment focus
  • Exhibit 77: Quidel - Key offerings
  • Exhibit 78: Quidel - Key customers
  • Exhibit 79: Validation techniques employed for market sizing
  • Exhibit 80: List of abbreviations